All were referred under the UK 2-week wait cancer referral pathway, when the referral criteria were PSA ≥3 ng/mL for men aged 50–69 years and ≥4 ng/mL for those aged 70–79 years or those with an abnormal rectal examination (DRE). All patients underwent multiparametric MRI (T2, ...
PSA testing by age J Fam Pract. 2000 Jul;49(7):659. Comment; Letter SN Forjuoh,GR Couchman,DB Cauthen - 《Journal of Family Practice》 被引量: 29发表: 2000年 PSA testing by age J Fam Pract. 2000 Jul;49(7):659. Comment; Letter S N Forjuoh,G R Couchman,D B Cauthen - 《...
Age‐Specific Reference Ranges for Prostate Specific Antigen in Young Men: Retrospective Study from the National Defense University Objectives: While controversial, the use of prostate specific antigen (PSA) testing is common and may reduce the morbidity and mortality associated with prostate cancer. ...
Blood PSA testing is used as a screening test for prostate cancer. Prostate-specific antigen (PSA) levels by age remain the same across most populations. A PSA level above 4.0 ng/mL in any age group must be investigated. However, PSA levels can spike in noncancerous conditions, such as ...
Prostate cancer screening with DRE, TRUS, and PSA testing was offered to 2,400 randomly selected men 55-70 years old. Among 1,782 examined, 65 (3.6%) men with prostate cancer were diagnosed. The PSA results were correlated to the diagnosis, the men's age, and the prostate volume. Least...
In the validation set, patients with polygenic hazard scores above the 50th centile accounted for 76% of cases of aggressive PCa, and the upper fifth accounted for 42%. Investigators expected the polygenic hazard score to modulate the positive predictive value of PSA testing in the validation set...
Background: The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effectjof screening with prostate-specific-antigen (PSA) testing on death rates from prostate cancer. Methods: We... Screening,Prostate Cancer Mortality in a Randomized Europea...
Hori, M.; Palmer, M. Japanese Journal of Clinical Oncology 51(1): 164-165 2021 ISSN/ISBN:1465-3621 33333553 10.1093/jjco/hyaa253 079042938 Article/Abstract emailed within 0-6 h Payments are secure & encrypted
Comparison with these two PRSs, EOPC-PRS indeed demonstrates the optimal predictive capacity for EOPC (Additional file 1: Fig. S17). Moreover, the EOPC-PRS could refine the discriminatory capability of PSA in men before 60 years old (Additional file 1: Fig. S18) from PLCO cohort. We ...
What Are the Best PsA Treatments for You? Understanding Biologics 10 Things People With Depression Wish You Knew What is hemoglobin POC or a hemoglobin blood test POC? “POC” refers to “point of care.” A POC test is one that is done on a machine at the site of care that yields...